FDA Approves New Treatment Option for Patients with ALS ...Middle East

SILVER SPRING, Md., Sept. 29, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease. "This approval provides another...

Hence then, the article about fda approves new treatment option for patients with als was published today ( Friday 30/09/2022 - 12:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves New Treatment Option for Patients with ALS )

Also on site :

• Sacramento's I Street bridge project clears major financial hurdle, bids for construction open in 1 month
• Is Luke Thompson Returning to ‘Bridgerton’ Season 5? Star Breaks Silence on Benedict’s Future (Exclusive)
• Trip.com Partners with JR Companies to Offer Nationwide Shinkansen Tickets to International Travellers